BMRN - $100 Invested In Biomarin Pharmaceutical 20 Years Ago Would Be Worth This Much Today | Benzinga
Biomarin Pharmaceutical (NASDAQ:BMRN) has outperformed the market over the past 20 years by 6.44% on an annualized basis producing an average annual return of 14.87%. Currently, Biomarin Pharmaceutical has a market capitalization of $16.09 billion.
Buying $100 In BMRN: If ...